One week after the treatment, on the irradiated side, (D) demonstrated lowest tumor volume (Figure 1), highest number of human PBMCs, highest % of CD8+ human T cells, highest % of CD45RO+CD4+ human (memory) T cells, and lowest % of PD-1+CD8+ human T cells in the tumors via flow cytometry (Figure 2), and highest IFN- gamma in the tumors via qRT-PCR, compared to the other five groups with statistical significance. The gene discussed is RPL17; the disease is neoplasm.